Farzaneh E Seyedi

age ~57

from Mansfield, MA

Get Report
Also known as:
  • Farzaneh Esfahani Seyedi
  • Esfahani Farzaneh Seyedi
  • Farzaneh Seyedi Esfahani
  • Farzaneh A
  • Farzaneh Isfahani
  • Farzaneh I
Phone and address:
43 Ridgeview Ln, Mansfield, MA 02048
Related to:
Connected to:

Farzaneh Seyedi Phones & Addresses

  • 43 Ridgeview Ln, Mansfield, MA 02048
  • Boston, MA
  • Canton, MA
  • Cambridge, MA
  • Warwick, RI
  • Cincinnati, OH
  • Providence, RI

Us Patents

  • Crystalline Salts Of (4S,4As,5Ar,12As)-4-Dimethylamino-3,10,12,12A-Tetrahydroxy-7-[(Methoxy(Methyl)Amino)-Methyl]-1,11-Dioxo-1,4,4A,5,5A,6,11,12A-Octahydro-Naphthacene-2-Carboxylic Acid Amide And Methods Of Using The Same

    view source
  • US Patent:
    20130012480, Jan 10, 2013
  • Filed:
    May 14, 2012
  • Appl. No.:
    13/471275
  • Inventors:
    Catherine Coulter - Ballymena, GB
    Sean M. Johnston - Doylestown PA, US
    Farzaneh Seyedi - Mansfield MA, US
  • Assignee:
    PARATEK PHARMACEUTICALS, INC. - Boston MA
    WARNER CHILCOTT COMPANY, LLC - Farjardo PR
  • International Classification:
    C07C 237/26
    A61P 31/04
    A61P 17/10
    A61P 17/00
    A61K 31/65
    C07C 309/04
  • US Classification:
    514152, 552203
  • Abstract:
    A crystalline mono hydrochloride salt of (4S,4aS,5aR,12aS)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide is disclosed having improved stability. In addition, a crystalline mono mesylate salt and crystalline mono sulfate salt of (4S,4aS,5aR,12aS)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide are also disclosed having improved stability. A pharmaceutical composition containing the crystalline salts and methods of treating inflammatory skin disorders and bacterial infections comprising administering the crystalline salts are also disclosed.

  • Methods Of Using (4S,4As,5Ar,12As)-4-Dimethylamino-3,10,12,12A-Tetrahydroxy-7-[(Methoxy(Methyl)Amino)-Methyl]-1,11-Dioxo-1,4,4A,5,5A,6,11,12A-Octahydro-Naphthacene-2-Carboxylic Acid Amide

    view source
  • US Patent:
    20130302442, Nov 14, 2013
  • Filed:
    May 14, 2013
  • Appl. No.:
    13/893717
  • Inventors:
    Farzaneh Seyedi - Mansfield MA, US
    Tina M. deVries - Long Valley NJ, US
  • Assignee:
    Paratek Pharmaceuticals, Inc. - Boston MA
    Warmer Chilcott Company, LLC - Fajardo PR
  • International Classification:
    A61K 31/65
    A61K 45/06
  • US Classification:
    424653, 514152, 514154
  • Abstract:
    A method of treating a bacterial infection, e.g., a bacterial infection with methicillin resistant , or , comprising administering to a subject (4S,4aS,5aR,12aS)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide or a pharmaceutically acceptable salt thereof is disclosed. More specifically, a method of treating a bacterial infection comprising administering to a subject crystalline mono hydrochloride salt, crystalline mono mesylate salt or crystalline mono sulfate salt of (4S,4aS,5aR,12aS)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide is disclosed.

  • Methods For Synthesizing Substituted Tetracycline Compounds

    view source
  • US Patent:
    20090156842, Jun 18, 2009
  • Filed:
    Jul 7, 2008
  • Appl. No.:
    12/217709
  • Inventors:
    Farzaneh Seyedi - Mansfield MA, US
    Tadeusz Warchol - Northborough MA, US
    Mark Grier - Medford MA, US
  • International Classification:
    C07C 237/26
  • US Classification:
    552204, 552205
  • Abstract:
    Methods of synthesizing substituted tetracycline compounds are provided.

  • Process For Making Sarecycline Hydrochloride

    view source
  • US Patent:
    20210017123, Jan 21, 2021
  • Filed:
    Apr 5, 2019
  • Appl. No.:
    17/043017
  • Inventors:
    - Boston MA, US
    - Exton PA, US
    Giuseppe MOTTA - Rescaldina, IT
    Meinrad BRENNER - Steg, CH
    Ruiliang LU - Guangzhou, CN
    Shaozhi HUANG - Foshan, CN
    William Paul ARMSTRONG - Carrickfergus, GB
    Gajanan JOSHI - South Plainfield NJ, US
    Farzaneh SEYEDI - Boston MA, US
    Sean JOHNSTON - Boston MA, US
  • International Classification:
    C07C 231/12
  • Abstract:
    The described invention relates to sarecycline, related compounds, intermediates and salts thereof and processes for preparing the same.

  • Crystalline Salts Of (4S,4As,5Ar,12As)-4-Dimethylamino-3,10,12,12A-Tetrahydroxy-7-[(Methoxy(Methyl)Amino)-Methyl]-1,11-Dioxo-1,4,4A,5,5A,6,11,12A-Octahydro-Naphthacene-2-Carboxylic Acid Amide And Methods Of Using The Same

    view source
  • US Patent:
    20200024223, Jan 23, 2020
  • Filed:
    May 15, 2019
  • Appl. No.:
    16/412986
  • Inventors:
    - Dublin, IE
    - Boston MA, US
    Farzaneh SEYEDI - Mansfield MA, US
  • International Classification:
    C07C 237/26
    C07C 239/20
    C07C 309/04
  • Abstract:
    A crystalline mono hydrochloride salt of (4S,4aS,5aR,12aS)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide is disclosed having improved stability. In addition, a crystalline mono mesylate salt and crystalline mono sulfate salt of (4S,4aS,5aR,12aS)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide are also disclosed having improved stability. A pharmaceutical composition containing the crystalline salts and methods of treating inflammatory skin disorders and bacterial infections comprising administering the crystalline salts are also disclosed.

  • Crystalline Salts Of (4S,4As,5Ar,12As)-4-Dimethylamino-3,10,12,12A-Tetrahydroxy-7-[(Methoxy(Methyl)Amino)-Methyl]-1,11-Dioxo-1,4,4A,5,5A,6,11,12A-Octahydro-Naphthacene-2-Carboxylic Acid Amide And Methods Of Using The Same

    view source
  • US Patent:
    20190040002, Feb 7, 2019
  • Filed:
    Mar 6, 2018
  • Appl. No.:
    15/913504
  • Inventors:
    - Dublin, IE
    - Boston MA, US
    Farzaneh SEYEDI - Mansfield MA, US
  • International Classification:
    C07C 237/26
    C07C 309/04
    C07C 239/20
  • Abstract:
    A crystalline mono hydrochloride salt of (4S,4aS,5aR, 12aS)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1, 11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide is disclosed having improved stability. In addition, a crystalline mono mesylate salt and crystalline mono sulfate salt of (4S,4aS,5aR,12aS)-4-dimethylamino-3, 10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1, 4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide are also disclosed having improved stability. A pharmaceutical composition containing the crystalline salts and methods of treating inflammatory skin disorders and bacterial infections comprising administering the crystalline salts are also disclosed.

  • Crystalline Forms Of A Histone Deacetylase Inhibitor

    view source
  • US Patent:
    20170001965, Jan 5, 2017
  • Filed:
    Jun 8, 2016
  • Appl. No.:
    15/176788
  • Inventors:
    - Boston MA, US
    Farzaneh Seyedi - Mansfield MA, US
    Gui Liu - Lexington MA, US
  • International Classification:
    C07D 239/42
  • Abstract:
    This disclosure provides solid forms of 2-((2-chlorophenyl)(phenyl)amino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide, and methods of manufacturing and using these forms.

  • Crystalline Salts Of (4S, 4As, 5Ar, 12As)-4-Dimethylamino-3,10,12,12A-Tetrahydroxy-7-[(Methoxy(Methyl)Amino)-Methyl]-1,11-Dioxo-1,4,4A,5,5A,6,11,12A-Octahydro-Naphthacene-2-Carboxylic Acid Amide And Methods Of Using The Same

    view source
  • US Patent:
    20160200671, Jul 14, 2016
  • Filed:
    Dec 18, 2015
  • Appl. No.:
    14/974813
  • Inventors:
    - Fajardo PR, US
    - Boston MA, US
    Farzaneh SEYEDI - Mansfield MA, US
  • International Classification:
    C07C 237/26
  • Abstract:
    A crystalline mono hydrochloride salt of (4S,4aS,5aR,12aS)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide is disclosed having improved stability. In addition, a crystalline mono mesylate salt and crystalline mono sulfate salt of (4S,4aS,5aR,12aS)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide are also disclosed having improved stability. A pharmaceutical composition containing the crystalline salts and methods of treating inflammatory skin disorders and bacterial infections comprising administering the crystalline salts are also disclosed.
Get Report for Farzaneh E Seyedi from Mansfield, MA, age ~57
Control profile